Evaluation of the Role of hsa-mir-124 in Predicting Clinical Outcome in Breast Invasive Carcinoma Based on Bioinformatics Analysis

Figure 2

The expression of hsa-mir-124 was associated with TNM stages in breast invasive carcinoma. The Kruskal–Wallis test and Wilcox test were used to analyse the association of hsa-mir-124 and pathology TNM stages in TCGA-BRCA. (a) hsa-mir-124-1, (b) hsa-mir-124-2, and (c) hsa-mir-124-3 in T stage; (d) hsa-mir-124-1, (e) hsa-mir-124-2, and (f) hsa-mir-124-3 in N stage; and (g) hsa-mir-124-1, (h) hsa-mir-124-2, and (i) hsa-mir-124-3 in M stage.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)